Is the current use of 'positivity' thresholds meaningful for evaluating HIV-vaccine immunogenicity endpoints?

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1097/QAD.0b013e328360d52e

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.